Диссертация (1139658), страница 37
Текст из файла (страница 37)
Новые подходы к диагностике и профилактикедетского туберкулеза / И. Н. Флетчер, Н. В. Жебуртович // Проблемытуберкулеза. – 2002. – № 4. – С. 3-5.218126.Фтизиатрия. Национальное руководство / Ассоц. мед. о-в по качеству,Рос. о-во фтизиатров ; ред. М.И. Перельман. – Москва : Гэотар-Медиа, 2010.– 504 с.127.Хаитов, Р. М. Современные представления о защите организма отинфекции / Р. М. Хаитов, Б. В. Пинегин // Иммунология. – 2000. – № 1. – С.61-64.128.Халафян, А. А. STATISTICA 6. Статистический анализ данных :учебник / А.
А. Халафян. – 3-е изд. – Москва : Бином-Пресс, 2008. – 512 с.129.Шилова, М. В. Туберкулез в России / М. В. Шилова. – Москва, 2014. –244 с.130.Шмаков, П. Ю. Медико-социальная характеристика контингента частоболеющих детей с различным иммунным статусом и пути их оздоровления :автореф. дис. … канд.
мед. наук / П. Ю. Шмаков. – Рязань, 2002. – 23 с.131.Экспериментальное исследование иммунотропного и протективногоэффекта«бустирования»вакциныБЦЖгриппознымвектором,экспрессирующим микобактериальные белки / Н. В Заболотных [и др.] //Сборник тезисов II Конгресса национальной ассоциации фтизиатров. –Санкт-Петербург, 2013. – С. 257.132.Эффективность определения первичной туберкулезной инфекции удетей и подростков с помощью анализа антиген-специфической продукцииинтерферона-гамма в образцах крови in vitro / М.А.
Владимирский [и др.] //Туберкулез и болезни легких. – 2013. – № 6. – С. 22-23.133.A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis / P. O.Flores-Villanueva [et al.] // J. Exp. Med. – 2005. – Vol. 202, № 12. – P. 16491658.134.A multistage tuberculosis vaccine that confers efficient protection beforeand after exposure / C. Aagaard [et al.] // Nat. Med. – 2011.
– Vol. 17, № 2. – P.189–194.219135.A mutation in the interferon gamma-receptor gene and susceptibility tomycobacterial infection / M. J. Newport [et al.] // N. Engl. J. Med. – 1996. – Vol.335, № 26. – P. 1941–1949.136.A recombinant adenovirus expressing immunodominant TB antigens cansignificantly enhance BCG-induced human immunity / D.
F. Hoft [et al.] //Vaccine. – 2012. – Vol. 30, № 12. – P. 2098–2108.137.A refined symptom-based approach to diagnose pulmonary tuberculosis inchildren / B. J. Marais [et al.] // Pediatrics. – 2006. – Vol. 118. – e1350–1359.138.A replication clock for Mycobacterium tuberculosis / W.
P. Gill [et al.] //Nat. med. – 2009. – Vol. 15, № 2. – P. 211-214.139.Aberrant DNA methylation and gene expression in livers of newborn micetransplacentally exposed to a hepatocarcinogenic dose of inorganic arsenic / Y.Xie [et al.] // Toxicology. – 2007. Vol. 236, № 1–2. – P. 7–15.140.Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonarytuberculosis in children admitted to hospital in Cape Town, South Africa: adescriptive study / M. P.
Nicol [et al.] // Lancet Infect. Dis. – 2011. – Vol. 11. –P. 819–824.141.Achkar, J. M. Antibody responses to mycobacterial antigens in childrenwith tuberculosis: challenges and potential diagnostic value / J. M. Achkar, A.Ziegenbalg // Clin. Vaccine Immunol. – 2012. – Vol. 19, № 12. – P. 1898-906.142.Aerosol infection of mice with recombinant BCG secreting murine IFN-gamma partially reconstitutes local protective immunity / A. L.
Moreira [et al.] //Microb. Pathog. – 2000. – Vol. 29, № 3. – P. 175–185.143.Ahmad,S.Pathogenesis,immunology,anddiagnosisoflatentMycobacterium tuberculosis infection [Electronic resource] / S. Ahmad // Clin.Dev. Immunol. – 2011. – P. 814943. – doi: 10.1155/2011/814943.144.Akira, S. Toll-like receptors: critical proteins link-ing innate and acquiredimmunity / S.
Akira, K. Takeda, T. Kaisho // Nat. Immunol. – 2001. – Vol. 2, №8. – P. 675–680.220145.Al-Zamel, F. A. Detection and diagnosis of Mycobacterium tuberculosis /F. A. Al-Zamel // Expert Rev. Anti. Infect Ther. – 2009. – Vol. 7, № 9. – P. 10991108.146.An essential role for phoP in Mycobacterium tuberculosis virulence / E.Perez [et al.] // Mol. Microbiol. – 2001. – Vol. 41. – P. 179-187.147.Analysis of cellular phenotypes that mediate genetic resistance totuberculosis using a radiation bone marrow chimera approach / K.
B. Majorov [etal.] // Infect. Immunity. – 2005. – Vol. 73. – P. 6174-6178.148.Apoptosis-associated biomarkers in tuberculosis: promising for diagnosisand prognosis prediction / C. C. Shu [et al.] // BMC Infect. Dis. – 2013. – Vol.13. – P. 45.149.Apoptosis is an innate defense function of macrophages againstMycobacterium tuberculosis / S. M. Behar [et al.] // Mucosal. Immunol. – 2011.
–Vol. 4, № 3. – Р. 279–87. – doi: 10.1038/mi. 2011.3.150.ApoptoticneutrophilsaugmenttheinflammatoryresponsetoMycobacterium tuberculosis infection in human macrophages / H. Andersson [etal.] // PLoS ONE. – 2014. – № 9. – e101514.151.Apoptotic vesicles crossprime CD8 T cell sand protect against tuberculosis/ F. Winau [et al.] // Immunity. – 2006. – Vol. 24. – P. 105–117.152.Appelberg,R. Neutrophilsandintracellularpathogens:beyondphagocytosis and killing / R.
Appelberg // Trends Microbiol. – 2007. – № 2. – P.87–92. – doi: 10.1016/j.tim.2006.11.009.153.Apt, A. Tuberculosis: pathogenesis, immune response, and host genetics /A. Apt, T. Kondratieva // Mol. Biol. – 2008. – Vol. 42. – P.784-793.154.Are the PE-PGRS proteins of Mycobacterium tuberculosis variable surfaceantigens? S. Banu [et al.] // Mol.
Microbiol. – 2002. – Vol. 44, № 1. – P. 9-19.155.Arnson, Y. Effects of tobacco smoke on immunity, inflammation andautoimmunity / Y. Arnson, Y. Shoenfeld, H. Amital / J. Autoimmun. – 2010. –Vol. 34, № 3. – P. J258–65.221156.Artificial intelligence – neural networks [Electronic resource]. [Cited July2016].–URL:www.tutorialspoint.com/artificial_intelligence/artificial_intelligence_neural_networks.html. – [Access date: 27.10.2017].157.Asha, T. Diagnosis of tuberculosis using ensemble methods [Electronicresource].
[Cited Jan. 2017] / T. Asha, S. Natarajan, K. N. B. Murthy. – URL:www.meeting.edu.cn/meeting/UploadPapers/1282705343515.pdf.–[Accessdate: 27.10.2017].158.Assessing the serodiagnostic potential of 35 Mycobacterium tuberculosisproteins and identification of four novel serological antigens / K. Weldingh [etal.] // J. Clin.
Microbiol. – 2005. – Vol. 43. – P. 57–65.159.Assessment of T cell response to novel Mycobacterium tuberculosissynthetic overlapping peptides mixtures (Rv2659 and Rv2660) and ESAT-6 inEgyptian patients / A. M. Salman [et al.] // Egypt J. Immunol. – 2014. – Vol. 21,№ 2. – P. 75-83.160.Autocrine transforming growth factor-beta1 promotes in vivo Th17 celldifferentiation / I.
Gutcher [et al.] // Immunity. – 2011. – Vol. 34, № 3. – Р. 396–408. – doi: 10.1016/j.immuni.2011.03.005.161.Boosting BCGwithMVA85A: the first candidate sub unit vaccine fortuberculosis in clinical trials / H. McShane [et al.] // Tuberculosis. – 2005. – Vol.85, № 1-2. – P. 47–52.162.Bottai, D. Mycobacterial PE, PPE and ESX clusters: novel insights into thesecretion of these most unusual protein families / D. Bottai, R.
Brosch // Mol.Microbiol. – 2009. – Vol. 73. – P. 325-328.163.Brennan, M. J. The PE multigene family: a 'molecular mantra' formycobacteria / M. J. Brennan, G. Delogu // Trends Microbiol. – 2002. – Vol. 10.– P. 246-249.164.Brewer, T. F. Preventing tuberculosis with bacillus Calmette-Guerinvaccine: a meta-analysis of the literature / T. F. Brewer // Clin. Infect Dis. –2000. – Vol. 31, suppl. 3. – P. S64–67.222165.Burtis, C. A.
Tietz Textbook of Clinical Chemistry and MolecularDiagnostics / C. A. Burtis, E. R. Ashwood, D. E. Bruns. – 4-th ed. – New Delhi :Elsevier, 2006. – 2412 p.166.Cardona, P. J. A dynamic reinfection hypothesis of latent tuberculosisinfection / P. J. Cardona // Infection. – 2009. – Vol. 37. – P. 80-86.167.Cardona, P. J. On the nature of Mycobacterium tuberculosis-latent bacilli /P. J. Cardona, J. Ruiz-Manzano // Eur. Respir. J. – 2004.
– Vol. 24. – P. 10441051.168.Cardona, P. J. Revisiting the natural history of tuberculosis. The inclusionof constant reinfection, host tolerance, and damage-response frameworks leads toa better understanding of latent infection and its evolution towards active disease/ P.
J. Cardona // Arch. Immunol. Ther. Exp (Warsz). – 2010. – Vol. 58, № 1. – P.7-14.169.CD4+ T cell persistence and function after infection are maintained by low-level peptide:MHC class II presentation / R. W. Nelson [et al.] // J. Immunol. –2013.
– Vol. 190. – P. 2828–34.170.Cell biology of mycobacterium tuberculosis phagosome / I. Vergne [et al.]// Annu Rev. Cell Dev. Biol. – 2004. – Vol. 20. – P. 367-394.171.Centers for Disease Control and Prevention (CDC). Updated guidelines forusing Interferon Gamma Release Assays to detect Mycobacterium tuberculosisinfection / G.
H. Mazurek et al. // MMWR Recomm. Rep. – 2010. – Vol. 59, №RR-5. – P. 1–25.172.Chan, E. D. What is the role of nitric oxide in murine and human hostdefense against tuberculosis? Current knowledge / E. D. Chan, J. Chan, N. W.Schluger // Am. J. Respir. Cell Mol. Biol. – 2001. – Vol. 25. – P. 606–612.173.Chao, M. C. Letting sleeping dos lie: does dormancy play a role intuberculosis? // M. C. Chao, E. J.
Rubin // Annu Rev. Microbiol. – 2010. – Vol.64. – P. 293-311.223174.Characterization of pandemic influenza immune memory signature aftervaccination or infection / O. Bonduelle [et al.] // J. Clin. Invest. – 2014. – Vol.124. – P. 3129–3136.175.Chronic pneumonia despite adaptive immune response to Mycobacteriumbovis BCG in MyD88-deficient mice / D. M.
Nicolle [et al.] // Lab. Invest. –2004. – Vol. 84. – P. 1305– 1321.176.Commercial interferon gamma release assays compared to the tuberculinskin test for diagnosis of latent Mycobacterium tuberculosis infection inchildhood contacts in the Gambia / I. M. Adetifa [et al.] // Pediatr. Infect Dis. J. –2010. – Vol. 29, № 5. – P. 439–443.177.Comparativeevaluationoflow-molecular-massproteinsfromMycobacterium tuberculosis identifies members of the ESAT-6 family asimmunodominant T-Cell antigens / R. L. V. Skjot [et al.] // Infect. Immunity. –2000. – Vol.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
